Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-11-06

Clinical Trial Update: An Intervention Program to Reduce to the Risk of Persistent Symptoms After Concussion [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating an intervention program to reduce persistent symptoms after concussion in mild traumatic brain injury has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of British Columbia | Conditions: Mild Traumatic Brain Injury | Phase 2 | Status: COMPLETED